Stock-Based Compensation

$5.35M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$5.35Mperiod endingJun 30, 2026

IKT Quarterly Stock-Based Comp ($75.19K → $5.35M)

Quarterly stock-based compensation

High-resolution chart · PNG

IKT stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	5,346,010
Mar 31, 2026	5,559,766
Dec 31, 2025	4,533,780
Sep 30, 2025	4,525,206
Jun 30, 2025	4,208,742
Mar 31, 2025	2,042,196
Dec 31, 2024	7,908,462
Sep 30, 2024	148,024
Jun 30, 2024	30,697
Mar 31, 2024	53,434
Dec 31, 2023	122,249
Sep 30, 2023	129,781
Jun 30, 2023	124,845
Mar 31, 2023	123,273
Dec 31, 2022	100,363
Sep 30, 2022	101,788
Jun 30, 2022	132,767
Mar 31, 2022	123,229
Dec 31, 2021	265,850
Sep 30, 2021	352,419
Jun 30, 2021	322,483
Mar 31, 2021	591,124
Dec 31, 2020	154,420
Sep 30, 2020	139,758
Jun 30, 2020	0
Mar 31, 2020	139,758
Dec 31, 2019	140,359
Sep 30, 2019	872,026
Jun 30, 2019	91,090
Mar 31, 2019	333,133
Mar 31, 2018	166,574
Mar 31, 2017	75,185